Security key
76155X100
Revolution Medicines, Inc. - Common Stock (RVMD)
CUSIP: 76155X100
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 191,051,347
- Total 13F value
- $6,776,444,446
- Share change
- -2,259,360
- Put/Call ratio
- 361%
- SEC-reported price per share
- $35.36
- Number of holders
- 281
- Value change
- -$111,943,197
- Number of buys
- 142
- Number of sells
- 129
- Shares outstanding
- 199,316,245
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2025
Institutions
281
Top holders
10
RVMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76155X100
Recent filing periods:
Ownership snapshot
Top reported holders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 8.6%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 8.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
VANGUARD GROUP INC
8.6%
BlackRock, Inc.
7.4%
WELLINGTON MANAGEMENT GROUP LLP
5.4%
JANUS HENDERSON GROUP PLC
4.8%
BAKER BROS. ADVISORS LP
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
8.6%
|
$747,798,942
17,096,455 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
7.4%
|
$643,833,029
14,719,548 shares
|
— | 31 Dec 2024 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
5.4%
|
$473,340,765
10,821,691 shares
|
— | 31 Dec 2024 |
| JANUS HENDERSON GROUP PLC |
13F
Company
|
4.8%
|
$414,777,363
9,483,999 shares
|
— | 31 Dec 2024 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
4%
|
$347,163,155
7,936,972 shares
|
— | 31 Dec 2024 |
| Nextech Invest Ltd. |
13F
Company
|
3.8%
|
$332,471,545
7,601,087 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
281
Shares
191,051,347
Rows available
281
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
278
Q1 2025 holders
281
Holder diff
3
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend